Showing results (41-50 of 59) with videos related to
Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|May 17, 2011
Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppressionR Charles Nichols, Christopher G Morris, Bradford S Hoppe, et al.Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicityR Charles Nichols, Thomas J George, Robert A Zaiden, et al.International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018William F Regine, Frederick A Schmitt, Charles B Scott, et al.Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.Acta Oncologica (Stockholm, Sweden)|May 13, 2020
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancerShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.Journal of Medicinal Chemistry|February 20, 2004
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analoguesJohn T Randolph, Philip Waid, Charles Nichols, et al.International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.World Journal of Gastrointestinal Surgery|May 16, 2017
Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancerKathryn E Hitchcock, R Charles Nichols, Christopher G Morris, et al.Pageof 6